COVID-19

Your central place to rapidly access latest news, translated guidance information, and expert interpretations from our former regulators related to COVID-19. Parexel’s 1000+ consulting experts are closely following agency announcements and new guidances and can help provide deep expertise and experience in the race to bring this outbreak to a close. We’re here to fight this with you.

  • COVID-19 Health Authority updates

    COVID-19 Health Authority updates

    A summary of global health authorities updates in response to COVID-19.

    View Now
  • The Special Approval Pathway (SAP) for COVID-19 related products in China

    The Special Approval Pathway (SAP) for COVID-19 related products in China

    The regulatory pathway for COVID-19 drugs in China is governed by the Special Approval Program (SAP) which was introduced by National Medical Product Administration (NMPA) in 2005.  SAP is...

    Learn More
  • See Parexel's latest COVID-19 expert content

    View all
  • Against All Odds: Can Covid-19 Usher in a New Era in International Public Health Cooperation?

    Against All Odds: Can Covid-19 Usher in a New Era in International Public Health Cooperation?

    Key Takeaways The COVID-19 pandemic has drawn attention to international efforts to promote...

    Learn More
  • Coronavirus (COVID-19) Update: April 9, 2021

    Coronavirus (COVID-19) Update: April 9, 2021

    The FDA recommends health care personnel and facilities transition from the use of decontaminated disposable respirators, and issues warning letters to two companies for selling unapproved...

    Learn More
  • Visit Parexel's COVID 19 Clearinghouse

    Visit Now
  • CDER Scientific Review Documents Supporting Emergency Use Authorizations for Drug and Biological Therapeutic Products | COVID-19

    CDER Scientific Review Documents Supporting Emergency Use Authorizations for Drug and Biological Therapeutic Products | COVID-19

    CDER Scientific Reviews Supporting EUA for Therapeutic Products

    Learn More
  • Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 April 2021, PRAC, 09/04/2021

    PRAC conclusion on very rare cases of unusual blood clots with low blood platelets with Vaxzevria (AstraZeneca’s COVID-19 vaccine)EMA’s safety committee...

    Learn More
  • About Mineral - 613984 - 04/07/2021

    About Mineral - 613984 - 04/07/2021

    Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19)

    Learn More
  • Allure Imports - 613211 - 04/07/2021

    Allure Imports - 613211 - 04/07/2021

    Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19)

    Learn More
  • AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets, PRAC, 07/04/2021

    EMA confirms overall benefit-risk remains positiveEMA’s safety committee (PRAC) has concluded today that unusual blood clots with low blood platelets...

    Learn More
  • Preparing for the Future — Nanobodies for Covid-19?

    New England Journal of Medicine, Ahead of Print.

    Learn More
  • Coronavirus (COVID-19) Update: April 6, 2021

    Coronavirus (COVID-19) Update: April 6, 2021

    Coronavirus (COVID-19) Update: April 6, 2021

    Learn More
  • Coronavirus (COVID-19) Update: April 6, 2021

    Coronavirus (COVID-19) Update: April 6, 2021

    Coronavirus (COVID-19) Update: April 6, 2021

    Learn More
  • Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization for the Symbiotica COVID-19 Self-Collected Antibody Test System

    Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization for the Symbiotica COVID-19 Self-Collected Antibody Test System

    The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the Symbiotica COVID-19 Self-Collected Antibody Test System.

    Learn More
  • Sparrow Health & Performance LLC - 608460 - 12/21/2020

    Sparrow Health & Performance LLC - 608460 - 12/21/2020

    Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19)

    Learn More
  • Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19

    New England Journal of Medicine, Ahead of Print.

    Learn More
  • Development of Abbreviated New  Drug Applications During the  COVID-19 Pandemic – Questions and  Answers Guidance for Industry

    Development of Abbreviated New Drug Applications During the COVID-19 Pandemic – Questions and Answers Guidance for Industry

    Development of Abbreviated New Drug Applications During the COVID-19 Pandemic – Questions and Answers Guidance for Industry

    Learn More
  • Coronavirus (COVID-19) Update: April 2, 2021

    Coronavirus (COVID-19) Update: April 2, 2021

    Coronavirus (COVID-19) Update: April 2, 2021

    Learn More
  • Coronavirus (COVID-19) Update: April 2, 2021

    Coronavirus (COVID-19) Update: April 2, 2021

    Coronavirus (COVID-19) Update: April 2, 2021

    Learn More
  • Natural Adventure, LLC - 612267 - 04/01/2021

    Natural Adventure, LLC - 612267 - 04/01/2021

    Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19)

    Learn More
  • Coronavirus (COVID-19) Update: FDA Makes Two Revisions to Moderna COVID-19 Vaccine Emergency Use Authorization to Help Increase the Number o

    Coronavirus (COVID-19) Update: FDA Makes Two Revisions to Moderna COVID-19 Vaccine Emergency Use Authorization to Help Increase the Number o

    The FDA announced two revisions regarding the number of doses per vial available for the Moderna COVID-19 Vaccine.

    Learn More
  • loading
    Loading More...